Pursuant to Regulation 29 read with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Eris Lifesciences has informed that a meeting of the Board of Directors is scheduled to be held on Saturday, 3rd November, 2018 to, inter alia, consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter / half year ended 30th September, 2018.Further, pursuant to SEBI [Prohibition of Insider Trading] Regulations, 2015 and Policy on “code of conduct to regulate, monitor and report trading by Insiders” of the Company, the Trading Window for dealing in shares of the Company will remain closed from 26th October, 2018 to 5th November, 2018 for the purpose of this board meeting.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1800.30 |
Dr. Reddys Lab | 1275.05 |
Cipla | 1472.05 |
Lupin | 2098.70 |
Zydus Lifesciences | 979.10 |
View more.. |